You do not currently have access to this content.
Cancer Res (2025) 85 (8_Supplement_2): ND07. FAP (Fibroblast Activation Protein) is expressed on cancer-associated fibroblasts (CAFs) and is a highly attractive target in Radioligand Therapy (RLT) due ...
Cancer Res (2025) 85 (8_Supplement_2): LB430.
B7-H3 (CD276), an immune checkpoint member of the B7/CD28 family, is widely expressed in multiple cancers and is associated with poor prognosis. YL201 is a novel B7-H3-targeting antibody-drug ...
Cancer Res (2024) 84 (7_Supplement): CT037. Methods. This single arm phase I study (NCT05025800) was conducted between 11/2021 and 9/2023 (data cut-off 12/2023). Adult pts with RR B-NHL who had ...
EGFR and HER3 are receptor tyrosine kinases that are highly expressed in multiple epithelial tumors. EGFR point mutations and small insertions within the kinase domain are common in lung cancer. HER3 ...
2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...
Cancer Discov (2026) 16 (8): OF1.
Abstract. Constitutive activation of the EGFR is common in cancer due to EGFR wild-type (EGFRwt) overexpression or the presence of mutant EGFR. Signaling by constitutively active NSCLC EGFR mutants or ...
Cancer Discov (2026) 16 (8): OF1.
Cancer Discov (2026) 16 (8): OF1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results